# The Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015, Paragraph 10


(1) A cannabis-based product for medicinal use in humans.
(2) A product which is—
(a) specified in Part 1 as a consequence of the application of paragraphs 2 to 5 to a preparation or other product (not being the substance specified in paragraph 9) which is or contains cannabis, cannabis resin, cannabinol or a cannabinol derivative (not being dronabinol or its stereoisomers); and
(b) produced for medicinal use in humans.
(3) In this paragraph—
“cannabis-based product for medicinal use in humans” means a preparation or other product (not being the substance specified in paragraph 9), which—
(a)is or contains cannabis, cannabis resin, cannabinol or a cannabinol derivative (not being dronabinol or its stereoisomers);
(b)is produced for medicinal use in humans; and
(c)is—
(i)a medicinal product, or
(ii)a substance or preparation for use as an ingredient of, or in the production of an ingredient of, a medicinal product; and
“medicinal product” has the same meaning as in the Human Medicines Regulations 2012.
(4) In this Schedule, “dronabinol” does not include any substance which—
(a) has the international non-proprietary name dronabinol (recommended by the World Health Organisation); and
(b) is derived from cannabis, cannabis resin or their constituents,
and stereoisomers of dronabinol are to be construed accordingly.

---
Source: https://www.legislation.gov.uk/uksi/2015/704/schedule/1/paragraph/10 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-designation-england-wales-and-scotland-order-2015/schedule-1/paragraph-10
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

